Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00055263 · ClinicalTrials.gov registry record · Phase 1
A New Formulation of Calcitriol (DN-101) in Patients With Advanced Malignancies
A Phase 1 study, sponsored by Novacea.
- Completed
- Registry status
- Phase 1
- Development phase
- 60
- Enrollment target
NCT00055263: Completed Phase 1 study, sponsored by Novacea.
NCT00055263 is a Phase 1 study that has completed, run by Novacea. The registered enrollment target is 60 participants, roughly in line with the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00055263, a Phase 1 study, has completed, sponsored by Novacea.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 60 participants
- Enrollment target
Study Summary
The purposes of this study are to: * Test the safety of DN-101 in patients with advanced malignancies * Understand how fast the body absorbs, processes, and eliminates DN-101 * Determine the highest dose of DN-101 that is well tolerated by cancer patients * Learn how fast the body absorbs, processes, and eliminates DN-101 compared to the approved product
Interventions
- DRUG DN-101
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2002-03 |
| Phase | Phase 1 |
What the finished NCT00055263 record still lists
NCT00055263 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, roughly in line with the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target.
The record links to 0 conditions, and to 1 intervention - of which DN-101 is the first listed.
NCT00055263 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00055263 about?
NCT00055263 is a clinical study titled "A New Formulation of Calcitriol (DN-101) in Patients With Advanced Malignancies". The purposes of this study are to: * Test the safety of DN-101 in patients with advanced malignancies * Understand how fast the body absorbs, processes, and eliminates DN-101 * Determine the highest dose of DN-101 that is well tolerated by cancer patients * Learn how fast the body absorbs, processe...
What is the current status of trial NCT00055263?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 60 participants. The study started on 2002-03.
What interventions are being tested in trial NCT00055263?
The interventions under investigation include: DN-101 (DRUG).
Who is sponsoring clinical trial NCT00055263?
This trial is sponsored by Novacea, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00055263's enrollment target sits among peer trials
60 831st of 2000 higher than 1,106 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia